Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2000
07/18/2000US6090811 Analgesic
07/18/2000US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
07/18/2000US6090753 Pyridazin-3-one derivatives, their use, and intermediates for their production
07/18/2000CA2022183C Arylpyrazole derivatives as anti-platelet agents
07/13/2000WO2000040578A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
07/13/2000WO2000040577A1 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12
07/13/2000WO2000040564A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
07/13/2000WO2000040554A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
07/13/2000WO2000040245A1 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
07/13/2000WO2000040210A2 Topical compositions comprising protected functional thiols
07/13/2000WO2000040087A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
07/13/2000WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors
07/13/2000WO2000013683A3 Novel nitrophenylaziridine compounds and their use as prodrugs
07/13/2000WO2000006597A9 Endogenous constitutively activated g protein-coupled orphan receptors
07/13/2000WO2000003737A9 Water-soluble drugs and methods for their production
07/13/2000CA2358955A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
07/13/2000CA2358939A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
07/13/2000CA2358241A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors
07/13/2000CA2356689A1 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12
07/13/2000CA2355342A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
07/12/2000EP1017673A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
07/12/2000EP1017395A1 Method for treating premenstrual or late luteal phase syndrome
07/12/2000EP0877734B1 Quinoline and quinazoline compounds useful in therapy
07/12/2000EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues
07/12/2000EP0720600B1 3-(3,4-dioxyphenyl)-pyrrolidines as type iv phosphodiesterase inhibitors for the treatment of inflammatory diseases
07/12/2000EP0690854B1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders
07/12/2000CN1260006A Complex formation between dsDNA and oligomer of heterocycles
07/12/2000CN1259943A Substituted aryluracils
07/12/2000CN1259942A Novel guanidine mimics as factor Xa inhibitors
07/12/2000CN1259936A Method for producing nitroguanidine derivatives
07/12/2000CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them
07/11/2000US6087496 Enzyme inhibitors
07/11/2000US6087380 Antithrombotic benzimidazoles; anticoagulants; 2-(n-(4-amidinophenyl)-aminomethyl)-benzimidazol-5-yl-carboxylic acids
07/11/2000US6087357 Piperazine derivatives as tachykinin antagonists
07/11/2000CA2030519C Acryloyl substituted pyrrole derivatives
07/06/2000WO2000039125A1 Piperidines as ccr5 modulators
07/06/2000WO2000039124A1 Thrombin inhibitors
07/06/2000WO2000039119A1 Novel inhibitors of farnesyl-protein transferase
07/06/2000WO2000039106A1 Acrylonitrile compounds
07/06/2000WO2000039105A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders
07/06/2000WO2000039101A1 Pyrimidine compounds
07/06/2000WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands
07/06/2000WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
07/06/2000WO2000039086A1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
07/06/2000WO2000039082A2 1,2-annelated quinoline derivatives
07/06/2000WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/06/2000WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
07/06/2000WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
07/06/2000WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
07/06/2000WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
07/06/2000WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia
07/06/2000WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
07/06/2000WO2000038687A1 Protease inhibitors
07/06/2000WO2000038684A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain
07/06/2000WO2000038680A1 Azabicycloalkanes as ccr5 modulators
07/06/2000WO2000038677A1 Indole and indolizidine derivatives for the treatment of migraine
07/06/2000WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000CA2358067A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain
07/06/2000CA2358047A1 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds
07/06/2000CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia
07/06/2000CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
07/06/2000CA2356671A1 Protease inhibitors
07/06/2000CA2356638A1 Indole and indolizidine derivatives for the treatment of migraine
07/06/2000CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia
07/06/2000CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
07/06/2000CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
07/06/2000CA2356141A1 Acrylonitrile compounds
07/06/2000CA2355744A1 Novel inhibitors of farnesyl-protein transferase
07/06/2000CA2355281A1 Thrombin inhibitors
07/06/2000CA2353961A1 Heteroaromatic derivatives having an inhibitory activity against hiv integrase
07/06/2000CA2352896A1 Pyrimidine compounds
07/05/2000EP1016914A1 Photographic element containing pyrazolone pug releasing coupler and imaging process employing same
07/05/2000EP1015436A1 Morpholinones as light stabilizers
07/05/2000EP1014984A1 Inhibitors of prenyl-protein transferase
07/05/2000EP1014976A1 Novel substituted imidazole compounds
07/05/2000EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/05/2000EP0637241B1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
07/04/2000US6084130 For treatment of central nervous system disorders
07/04/2000US6084082 Solid phase synthesis by attaching beta-lactam having nucleobase to solid support, deprotecting hydroxy group, reacting free hydroxyl group with beta-lactamtide having activated phosphite group, and oxidizing
07/04/2000US6083961 For prevention and/or treatment of bradykinin or its analogues mediated diseases such as allergy, inflammation, autoimmune disease, shock, pain
07/04/2000US6083485 Near infrared radiation in-vivo diagnostic methods and dyes
07/04/2000CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
06/2000
06/29/2000WO2000037462A1 Non-peptide nk1 receptors antagonists
06/29/2000WO2000037460A1 5-azolylpyrimidine compounds, process for the preparation of the same, and germicides for agricultural and horticultural use
06/29/2000WO2000037459A1 Tricyclic farnesyl protein transferase inhibitors
06/29/2000WO2000037456A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000004893A3 Imidazoline receptor binding compounds
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2355861A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2354779A1 Tricyclic farnesyl protein transferase inhibitors
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1011667A1 Antagonists of gonadotropin releasing hormone
06/28/2000EP0808318B1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists
1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 626